People who maintain that eating tomatoes can cause their gout to flare up are likely to welcome new University of Otago research that has, for the first time, found a biological basis for this belief.
Aug 19, 2015
0
42
New research in mice shows that two commonly used gout medications, which target uric acid and adenosine triphosphate, may offer protection from alcohol-induced liver disease and inflammation. These findings suggest that ...
Jul 31, 2015
0
14
Uric acid - a chemical at high levels can lead to serious illness - may lessen women's disability after stroke, according to new research in the American Heart Association's journal Stroke.
Jul 9, 2015
0
18
(HealthDay)—A combination of testosterone and fenofibrate may offer men with high cholesterol and late-onset hypogonadism the most cardiometabolic benefit, according to a study published online May 29 in Cardiovascular ...
Jun 17, 2015
0
6
People who have gout are significantly less likely to develop Alzheimer's disease, concludes research published online in the Annals of the Rheumatic Diseases.
Mar 4, 2015
0
27
Among patients in England with gout, only a minority of those with indications to receive urate-lowering therapy were treated according to guideline recommendations, according to a study in the December 24/31 issue of JAMA.
Dec 23, 2014
0
0
Tart cherries have long been researched for their association with pain relief – ranging from gout and arthritis joint pain to exercise-related muscle pain. A new study published in the Journal of Functional Foods is the ...
Oct 1, 2014
0
1
A new study suggests uric acid may play a role in causing metabolic syndrome, a cluster of risk factors that increases the risk of heart disease and type 2 diabetes.
Aug 8, 2014
0
1
Interested in antioxidants? They protect us against aging and cancer. It's one of the reasons we like our green tea and even our broccoli. But there is a new kid on the antioxidant block - uric acid. But wait, you're thinking, ...
May 27, 2014
0
0
(HealthDay)—The U.S. Food and Drug Administration has approved Sylvant (siltuximab) to treat patients with multicentric Castleman's disease (MCD), according to a news release issued by the agency today.
Apr 25, 2014
0
0
